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Angina and myocardial ischemia are usually caused by flow-limiting lesions within epicardial coronary arteries. However, several studies report that more than 20% of patients undergoing coronary angiography have no significant obstructive coronary artery disease (CAD) despite angina symptoms and/or noninvasive testing suggestive of myocardial ischemia. [1] [2] [3] Other potential causes of angina have been identified in these patients, including focal epicardial coronary spasm and epicardial endothelial dysfunction, 4 microvascular dysfunction, 5, 6 occult diffuse epicardial coronary disease, 7 and the presence of myocardial bridging. 8 The prevalence of these etiologies in the same population is poorly defined, and the percentage of patients without any of these abnormalities and presumably non-cardiac symptoms is also unknown.
Accordingly, the aim of this study was to investigate the potential underlying causes of angina in symptomatic patients with non-obstructive CAD by using a comprehensive combination of invasive investigations. Specifically, we tested for endothelial dysfunction with intracoronary acetylcholine (Ach), coronary microvascular dysfunction with the index of microcirculatory resistance (IMR) and coronary flow reserve (CFR), occult diffuse epicardial coronary disease with fractional flow reserve (FFR), and myocardial bridging with intravascular ultrasound (IVUS).
Methods

Study population
We evaluated adult patients who were electively referred to the cardiac catheterization laboratory for coronary angiography because of a clinical suspicion of coronary ischemia based on the presence of angina with or without an abnormal stress test. Typical angina was defined as having three characteristics: 1) substernal chest discomfort, 2) provoked by exertion or emotional stress, Accordingly, the aim of this study was to investigate the potential under rly ly lyin in ng ca c caus us uses es es o of angina in symptomatic patients with non-obstructive CAD by using a comprehensive co omb mb mbin in in t at atio io ion n n o of i inv nv nvas a ive investigations. Specifica ca cal lly y y, we tested for or r end dot ot oth h helial dysfunction with n ntr ra ac a oronary ac acet ety yl ylch ch chol ol lin in ine e e (A (A (Ach ch), ), ), c c cor oron on nary y y m m microv ov ovascu cu cula lar r dy dy ysf sfu un unct ctio ion n n w wi with th h t t the he i i ind nd ndex ex of f f mi mi icr cr c oc oc ocir ircu cu ula la lato t tory ry y re es esis ista tan nc nce e (I (I (IMR MR MR) ) ) a an and d d co co oro ro rona na n ry ry ry f fl flo ow w r r res s ser er erve ve ve ( ( (CF CF FR) R) R), , o o o c ccul ult t di di diff ff f us us se e e ep epi i ica ar ardi dia a al coronary dis sea ea ase se e w w wit it ith h fr fr frac cti ti tion on onal al l f f flo lo l w w w re re rese se erv rv rve e (F (F (FFR FR FR), ), ), a and nd d m m myo yo yoca ca card rd r ia ia al l br br brid id idgi gi ging ng n w w wit it ith h h in in ntr t avascular r and 3) relieved by rest and/or nitroglycerin. Atypical angina was defined as meeting two of the above characteristics. Exclusion criteria included the presence of an acute coronary syndrome, prior heart transplantation, prior percutaneous coronary intervention or coronary artery bypass grafting, renal insufficiency (creatinine>1.5mg/dL), abnormal ejection fraction (EF<55%), or presence of another likely explanation of angina such as pulmonary hypertension, hypertrophic cardiomyopathy, or valvular heart disease. All coronary vasodilating drugs were discontinued more than 48 hours before the examination, except for sublingual nitroglycerin as needed.
Patients had an overnight fast and peripheral blood samples were obtained for fasting lipids, serum glucose, insulin, and glycosylated hemoglobin. HOMA (homeostasis model assessment)
index was calculated to evaluate for insulin resistance. 9 A baseline coronary angiogram was performed via the femoral artery to rule out obstructive CAD (>50% diameter stenosis) in the right and left coronary arteries. In patients with non-obstructive CAD, the comprehensive invasive evaluation was conducted. The study was approved by Stanford's institutional review board and informed, written consent was obtained from all patients.
Coronary Endothelial Function Testing
Intravenous heparin (50-70 units/kg) was administered and a 6F guiding catheter without sideholes was used to engage the left main coronary artery. To test the endothelial function, 50 g Ach was slowly injected directly into the left coronary artery over 2-3 minutes. Unless there was significant bradycardia or severe vasoconstriction, 100 g of Ach was subsequently administered. After each injection, coronary angiography was performed. Offline, quantitative coronary angiography (QCA) was performed and endothelial dysfunction was diagnosed if the epicardial coronary artery diameter decreased by >20% compared to baseline. 10 Finally, a 200 g bolus of intracoronary nitroglycerin was administered and a coronary angiogram was obtained to ndex was calculated to evaluate for insulin resistance. 9 A baseline coronary ang gio io ogr gr ram m m w w was as as performed via the femoral artery to rule out obstructive CAD (>50% diameter stenosis) in the igh gh ht t t an an and d d le le left ft ft cor r ron on ona ary arteries. In patients with no no n n n n-obstructive CA CA C D, D, t t th he he comprehensive n nva a asi s ve evalu uat atio i i n n n w wa as s co co ond nd ndu uc ucte ted. 
Quantitative Coronary Angiography
The Stanford QCA Core Laboratory, blinded to the clinical, physiologic, and IVUS results, performed QCA on the left anterior descending artery (LAD) using the computer-assisted method QAngio XA7.3 (Medis) to determine the lumen diameter at baseline, after intracoronary Ach injection, and after intracoronary nitroglycerin administration. QCA was performed on the first 50-mm of length from the LAD ostium.
Coronary physiology measurements
Within 10 minutes after endothelial function testing, CFR, IMR, and FFR were measured by methods described previously. 11, 12 In brief, a pressure-temperature sensor guidewire (Certus Pressure Wire, St. Jude, St. Paul, Minnesota) was used for physiology measurements. With the sensor positioned at the tip of the catheter, the pressure measurement from the wire was equalized with that of the guiding catheter. The sensor was then positioned in the distal third of the LAD. Three injections of 3 mL of room temperature saline were made down the coronary artery, and the transit time was measured after each and averaged to calculate the resting mean transit time (Tmn). An intravenous infusion of adenosine (140 g/kg/min) was then administered via a large peripheral or central vein to induce steady state maximal hyperemia, and 3 more injections of 3 mL of room temperature saline were made. The transit time was measured after each and averaged to calculate the hyperemic Tmn. Simultaneous measurements of mean aortic pressure (Pa, by guiding catheter) and mean distal coronary pressure (Pd, by pressure wire) were also made during maximal hyperemia. IMR was calculated as the Pd at maximal hyperemia divided by the inverse of the hyperemic Tmn; 11 CFR was calculated as resting Tmn divided by hyperemic Tmn; and FFR was calculated by the ratio of mean Pd/mean Pa at maximal methods described previously. 11, 12 In brief, a pressure-temperature sensor guidew w wir ire e e (C C Cer r ertu tu tus s s Pressure Wire, St. Jude, St. Paul, Minnesota) was used for physiology measurements. With the e ens ns sor or r p p pos os sit it itio io ione ed d d a at at the tip of the catheter, the pr pr res e e s s sure measureme me m nt f f fro ro rom m the wire was eq qu ua ualized with h t tha ha hat t of of of the he he g g gui ui uidi d ding ng g c ca at ath h het t ter. T T Th h he se en ens sor r w wa was s th h hen en po os osit itio io ion ne ed d in in in t the he d d dis is ista tal l th th hi ir ird d d o o of h he e e LA LA LAD. D. T T Thr hr hree ee i inj nj jec ect ti tion on ns s of f f 3 3 mL mL mL o of f ro ro r om om om tem em mpe pe pera ra atu u ure re s s sal al alin n ne e e w we were re re m m mad ad de e do do dow wn wn t t the he he co o oro on onar ar ry artery, and th he e e tr tr ran an nsi si sit t ti ti t me me m w w was a a me me meas as sur ured ed ed a a aft ft fter er er e e eac ac ach h h an an a d d d av av aver er erag ag aged ed ed to o o ca ca calc lc lcul ul ulat at a e e th th the e e re re est st stin i g mean d hyperemia. 12 Microvascular dysfunction was defined as an IMR 25. 13, 14 An abnormal FFR was defined as 0.80.
Intravascular Ultrasound
IVUS was performed with a 40-MHz mechanical transducer ultrasound catheter (Atlantis SR Pro2, Boston Scientific Corp, Natick, Massachusetts) advanced down the LAD so that the IVUS transducer was positioned as close as possible to the pressure transducer mounted on the pressure
wire. An automated pullback at 0.5 mm/s was performed, and the IVUS images were stored onto DVD for offline analysis. Standard 2-dimensional and 3-dimensional measurements were performed as previously described. 12 All measurements were performed by the Stanford IVUS Core Laboratory, blinded to clinical, physiologic, and angiographic information.
The presence of a myocardial bridge (MB) was defined either by the identification of an echolucent half-moon sign and/or evidence of systolic compression ( 10% systolic compression during the cardiac cycle). 15 Maximum percent systolic compression was calculated by echoPlaque software (Indec Systems, Inc) and was defined as the change in vessel area during the cardiac cycle divided by vessel area during diastole.
Statistical Analysis
Normality of the data was determined using the Kolmogorov-Smirnov test and verified using histogram plots. Results are expressed as mean ± standard deviation for data following a normal distribution and median (25 th percentile to 75 th percentile) for data that were not normally distributed. Pearson's correlation test was performed to test association between normally distributed variables and Spearman's correlation test was used to test association between nonnormally distributed variables. Chi-square tests were used to assess for difference between categorical variables. Student's T-tests or Mann-Whitney rank-sum tests were used to assess for Core Laboratory, blinded to clinical, physiologic, and angiographic information. .
The presence of a myocardial bridge (MB) was defined either by the identification of an ec cho ho holu lu luc ce cent nt nt h h ha a alf--mo mo moo on sign and/or evidence of sys ys ysto o olic compressio io on n ( 10 10 10% % systolic compression d du duri ri ing n the car rdi di ia a ac cyc yc cle le). ) ). 15 difference between groups of continuous variables. Variables were tested for their ability to predict endothelial dysfunction, microvascular dysfunction, a low FFR, and myocardial bridging using univariable binary logistic regression analyses. Variables with a p value of <0.2 were considered for inclusion into multivariable forward stepwise models to determine independent correlates. Less signi cant univariables correlating signi cantly (R >0.6) with other variables in the model were removed to avoid multicollinearity. A two-sided p value of <0.05 was considered significant. Statistical analyses were performed using the SPSS 15.0 (SPSS, Chicago, IL).
Results
Between August 2007 and November 2012, a total of 139 patients completed endothelial function testing, 137 coronary physiology assessment, and 120 IVUS examination. There were no significant procedure-related complications, such as coronary dissection, myocardial infarction, life-threatening arrhythmia, major bleeding, or death.
Baseline characteristics of the study participants are shown in were referred directly to angiography without stress testing.
QCA, coronary physiology, and IVUS findings are shown in Table 2 Ba Ba ase se seli line ne e c c cha har ra ac ct ter eris sti ti t cs s s o o of f f t th the e st t tud ud udy y y pa pa part rti ic icip ip pan an nts ts s a a ar re re s s sho ho hown wn n i i in n Ta Ta abl bl le e e 1 1 1. . Th Th he e e me me ean an n a ag g ge was 54.0±11. 1.4 4 4 ye ye year ar ars s s (r (r (ran an a ge ge e 2 2 28 8 to to to 7 77 7 7 ye e ear ar ars) s) s a a and nd nd 1 1 107 07 7 p p pat tie ie ient nt nts s s (7 (7 (77. 7. 7.0% 0% %) ) ) we we were re re f f fem em mal al ale. e. e S S Sev e e enty four each abnormality are shown in Figure 1 . While most patients had only one occult coronary abnormality, many had more than one abnormality, with the combination of endothelial dysfunction and myocardial bridging being the most common (Figure 2A) . Thirty two patients (23.0%) had no coronary explanation for their angina, with normal endothelial function, normal coronary physiologic assessment (IMR, CFR, and FFR), and no myocardial bridging ( Figure 2B ). These patients tended to have less atherosclerotic burden based on IVUS examination of the LAD compared to the other 107 patients (maximum plaque burden, defined as the cross-section with the maximum plaque area divided by the vessel area times 100%: 33 ±20% vs. 39 ±19%, p=0.18). There was no correlation between the stress echocardiographic findings and each of the assessed coronary abnormalities.
However, 77% of the patients with at least one coronary circulatory abnormality had an abnormal stress test, while 44% of the patients without any coronary circulatory abnormality had a normal stress test (p=0.10).
Univariable correlates of endothelial dysfunction, microvascular dysfunction, low FFR, and myocardial bridging are shown in Table 3A . In a multivariable logistic regression model, diabetes was the only independent predictor of endothelial dysfunction, age was the only independent predictor of microvascular dysfunction, and homocysteine level was the only independent predictor of low FFR. There were no independent correlates of myocardial bridging (Table 3B) . Ho Ho owe we weve ve v r, r, , 7 7 77% 7% 7% o o of t th the e pa pa ati tie ents ts ts w w wit it ith h h a at at l l lea ea ast st st o o one e e c co o oro on ona ar ary y y ci ci cir r rcul ul ulat at tor or ry y y ab ab bno no orm rm mal al a it it ity y y ha ha had d a an an abnormal str res es ss s te te est st st, , wh wh while e e 44 44 44% % % of of o t t the h h p p pat at atie ie ient nt nts s s wi wi w th th thou ou o t an an any y y co co coro ro rona n n ry ry ry c c cir ir ircu cu cula la lato to ory ry ry a a abn bn bnor o o mality had d d
Discussion
The salient findings of this study are: 1) many patients with angina in the absence of obstructive CAD have occult coronary abnormalities; 2) on the other hand, a significant minority have no coronary etiology to explain their symptoms; and 3) a comprehensive invasive functional, physiologic, and anatomic coronary assessment allows safe stratification of patients without angiographic disease into specific potential etiologies for their chest pain.
Angina and myocardial ischemia are typically caused by flow-limiting lesions in the epicardial coronary arteries. When coronary angiography fails to reveal obstructive epicardial atherosclerosis, a diagnosis of non-cardiac chest pain is often given. Alternatively, in some cases, microvascular dysfunction is the presumptive diagnosis and anti-anginal therapy is instituted or escalated. In the former scenario, effective therapy and a potentially improved outcome may be withheld from a patient, while in the latter case, over-treatment causing unnecessary expense, side effects, and anxiety may occur. The lack of a clear diagnosis in the face of ongoing anginal symptoms can result in recurrent emergency room evaluations, hospitalizations, and repeat cardiac catheterizations, with adverse effects on quality of life, employment, and health care costs. 16, 17, 18 Moreover, patients who do have occult coronary abnormalities have higher cardiac event rates and may benefit from more aggressive treatment and follow-up. 4, 5, 19, 20, 21 Therefore, the precise assessment and diagnosis of angina in patients without angiographic evidence of CAD has important clinical implications.
In the current study, we found that 76.3% of patients had evidence of epicardial y ymp mp mpto to toms ms c c ca an an r re e esu ul ult t i in n r r rec ecur r rr re r nt nt nt e e eme m merg rg rgen en ency cy cy ro ro oom om om e e eva va alu u uat at atio io ions ns ns, , h ho hosp sp spit ita a aliz z zat atio io ions ns ns, , , an an and d d re e epe e eat at cardiac cathet et ter er eriz izat at atio io i ns ns n , , wi wi with th th adv dv dver er e se se s e e eff ff ffec ec ects ts ts o o on n n qu qu qual al alit ity y of of of li li life fe fe, , em em e pl pl ploy oy oyme me ment nt nt, , an an and d d he he heal al a th care studies in this patient population have generally focused on one entity, such as microvascular dysfunction or endothelial dysfunction, but not on the entire circulation, including the epicardial vessel (functional evaluation with Ach, physiologic assessment with FFR, and anatomic abnormalities with IVUS) and the microvasculature (IMR and CFR). 7, 8, [22] [23] [24] [25] 26, 27 This is the first study to thoroughly delineate the prevalence of each of these entities in the same population of patients. Of note, however, is the fact that we did not see any cases of focal epicardial spasm, another potential cause of angina in the absence of obstructive CAD. Likewise, microvascular spasm or endothelial dysfunction was not specifically evaluated, although this is challenging to do in vivo.
A second important finding in this study is the 23% rate of normal invasive findings.
Presumably these patients will do well without any specific cardiac medical therapy and alternative non-cardiac etiologies for their symptoms should be pursued. If long-term follow-up in this cohort demonstrates low event rates, it will further emphasize the need to distinguish this group from those with abnormal coronary circulation. Still, it is noteworthy that all patients had at least some evidence of atherosclerosis based on IVUS examination of the LAD, which may alter prevention management.
Although performing invasive coronary assessment with Ach administration, a coronary pressure wire, and IVUS does add time and expense to the procedure, a third main finding is that this assessment was completed on a routine basis and there were no significant procedural complications. Previous studies have provided information on safety, as well as low additional radiation and contrast exposure, in patients undergoing invasive functional studies to reveal occult coronary problems. [27] [28] [29] The extra time and expense may be offset by a reduction in further unnecessary testing or treatment, as well as a decrease in recurrent hospital visits and an A second important finding in this study is the 23% rate of normal invas si iv ive e e fi find nd ndin in ings gs gs. .
Presumably these patients will do well without any specific cardiac medical therapy and al lte te ern rn rnat at ati iv ive e e no no non-ca ca car rd rdiac etiologies for their sympt pt ptom om oms should be pu pu ursue ued d. d. I If long-term follow-up n n th hi his cohort d dem em mo on onst st tra ra ate te tes s s lo lo ow w w ev ev ven en nt t ra rat tes, it will l f f fu urth th he er er e emp m mpha ha asi ize e t the he h n nee ee ed d d to to d d dis is sti ti ting ngui ui uish sh sh th h his gr grou ou oup p p fr fr f om om m t t tho h hose se e w w wit ith h h a ab bno n rm rm mal al al c c cor or oron on nar ar ry y y ci ci circ c cul ul u a at atio o on. St St til il ill, l, l, it t t is is i n n not ot otew ew e or orth th t y y th th hat at a a a all ll l p pat at tie e ent nts s ha ha ad d at least some e ev ev evid id den en ence ce e o o of at at athe he hero o osc sc scle le ero ro r si si sis s ba ba base se sed d d on on n I IVU VU V S S S ex ex exam am amin in inat a io io ion n n of of of t t the he he L L LAD AD AD, , wh wh w ich may improvement in quality of life. However, a dedicated study is ultimately needed to determine if the performance of a comprehensive invasive assessment in patients with angina in the absence of obstructive CAD is cost-effective.
Other interesting findings in this study include the correlation between microvascular dysfunction and metabolic parameters, such as serum glucose, insulin, and HOMA index, as well as between microvascular dysfunction and cardiac risk factors, such as age, BMI, hypertension, and diabetes. Whether or not modifying these risk factors results in improved microvascular function and outcomes requires future investigation. We found the only independent predictor of microvascular dysfunction was patient age, which is consistent with results from the WISE study. 22 In addition, 5.1% of patients without obvious angiographic stenosis had an abnormal FFR, suggesting significant occult epicardial atherosclerosis as the cause for their symptoms and/or ischemia. 7 Identifying this group is important because they will likely benefit from aggressive medical therapy and potentially from revascularization. Finally, depending on the definition one chooses to diagnose myocardial bridging based on IVUS, it may be a prevalent finding in this patient population and may contribute to symptoms, either directly or as a result of its association with endothelial dysfunction.
Limitations
This is a relatively small, single center study. The complexity and expense of this strategy may limit its clinical application. Outcome data and whether or not outcomes can be modified with medical or interventional therapy are necessary to validate the importance of these findings. We performed invasive assessment only in the LAD; we may have neglected circulatory abnormalities in other coronary perfusion territories. There is no conclusive evidence that the occult coronary abnormalities identified in these patients are the cause of their symptoms.
tudy. 22 In addition, 5.1% of patients without obvious angiographic stenosis had d a a an ab ab bno n norm rm rmal al al FFR, suggesting significant occult epicardial atherosclerosis as the cause for their symptoms an nd/ d/ d/or or r i i isc sche he hemi m m a. a. 7 7 I I Ide d ntifying this group is impor or rta ta t n n nt because they y y will ll l l l li ik ikely benefit from ag ggr gres e sive med ed dic ic ica al l t the he h ra a apy py a a and nd nd p pot ot o e en ent ti ia al lly f f fro o om r r rev v vas scu cu cula lar r riz za ati tio on on. . However, previous studies in asymptomatic, "normal" controls have found that the normal mean FFR value is 0.97, the normal IMR is < 25, and the normal response to acetylcholine is vasodilation. [30] [31] [32] That the mean FFR in this study was 0.87, that 21% of patients had an IMR 25, and that any degree of vasoconstriction related to acetylcholine occurred in 76% all suggests these abnormalities may be related to symptoms. Unfortunately, symptom occurrence and electrocardiographic changes were not systematically recorded during Ach administration.
Finally, endothelial dysfunction or spasm isolated to the microvasculature was not specifically assessed.
Conclusions
On the basis of our findings, over three-quarters of patients with angina in the absence of Table 3B . Independent correlates for various coronary abnormalities verified by multivariable ogi gist st tic ic ic r r reg eg egre re ress s io o on n n an a alysis. 
